ATP6V1C2 and breast cancer: In the latter group, KRT16 [60], SERPINB3 [61], and ATP6V1C2 [67] exhibited activities favoring BC, while FA2H [58] and HRNR [64] possessed tumor-suppressive activities toward BC (Table 1).